INSMED Inc (INSM)
About INSMED Inc
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $606.4M
- Net income
- -$1.3B
- Total assets
- $2.3B
- Market cap
- $23.2B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $23.2B
- Shares outstanding
- 248.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 1, 2000
INSMED Inc (INSM) Stock Price
- Reported a net loss of $1.3B in FY2025.
- Trading 56% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review INSMED Inc.
Write a review
News about INSMED Inc
News & sentiment via Polygon.io
INSMED Inc: frequently asked questions
Is INSMED Inc an American company?
Yes — INSMED Inc is an American company headquartered in Bridgewater, New Jersey. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is INSMED Inc headquartered?
INSMED Inc is headquartered in Bridgewater, New Jersey, United States.
Is INSMED Inc publicly traded?
Yes — INSMED Inc is a publicly traded company. Its stock trades under the ticker symbol INSM on the NASDAQ.
What does INSMED Inc do?
INSMED Inc is an American Pharmaceuticals company in the Health & Beauty sector.
